John M. Rice possesses extensive experience in the biotechnology and medical device sectors. Currently serving as Partner Emeritus at CincyTech and Chairman of the Investment Advisory Board at the Harrington Discovery Institute, Rice is also a founder and board member of several companies, including Airway Therapeutics and Kurome Therapeutics. Rice's leadership roles include Chair of the Board of Directors at Kurome Therapeutics, board member positions at Armatus Bio, Inc., Enable Injections, Neurcore Bio, and AlveoGene, as well as previous chairman roles at Genetesis and Xact Medical. Rice holds a BS, MS, and Ph.D. in Microbiology and Virology from The Ohio State University, following an education at Euclid Senior High School.
This person is not in any teams
Harrington Discovery Institute at University Hospitals
The Harrington Discovery Institute at University Hospitals in Cleveland, OH – part of The Harrington Project for Discovery & Development – aims to advance medicine and society by enabling our nation’s most inventive scientists to turn their discoveries into medicines that improve human health. Harrington Discovery Institute was created in 2012 with a $50 million founding gift from the Harrington family and instantiates the commitment they share with University Hospitals to a Vision for a ‘Better World’.